Avania Names New Chief Operating Officer

Avania has appointed operational strategy expert Charlene Dark as chief operating officer (COO).

“As Avania guides sponsors through every stage of their product’s life cycle, Charlene’s data-driven decision-making, grounded in extensive clinical development experience, will be an asset to our clients and team,” Avania President/CEO Jason Monteleone said. “She plays a critical role in our next phase of growth supporting a flexible operating model that meets the diverse needs of our sponsors.”

Dark has more than 30 years of experience driving forward-thinking, risk-based strategies that fuel growth and profitability in the clinical development sector. She previously served as executive vice president of global clinical analytics at Clinipace, now Caidya, where she successfully drove commercial growth and operational efficiency of its global clinical analytics solution and spearheaded the development and adoption of the data aggregation and analytics offering.

“I am honored to step into the role of Avania’s COO and work alongside a dedicated team,” Dark stated. “As we navigate the evolving needs of the medtech industry, my focus will be on fostering innovation and aligning our operations to meet immediate challenges while positioning Avania for sustainable long-term success. Leveraging my experience in implementing actionable strategies and driving measurable outcomes, I am excited to help shape the future of medtech advisory and development, reinforcing Avania’s reputation as the industry standard.”

Avania is a global medtech advisory and clinical development partner with a focus on medical devices, diagnostics/IVDs, and digital health. Core offerings include full service clinical research outsourcing, market access, reimbursement, regulatory, and product development advisory services. Avania’s aims to be a global partner in the evolution of medical technology from innovation to commercialization to improving patient health and well-being.